Navigation Links
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
Date:11/22/2009

The Onder Law Firm’s attorneys are offering a free XOLAIR case review to those or families of those who may have experienced heart attack, stroke or other serious health problems after taking XOLAIR.

St. Louis, MO (Vocus) November 22, 2009 -- The Onder Law Firm are among attorneys offering free XOLAIR case review for serious health problems such as heart attack and stroke. The attorneys of the Onder Law Firm include experienced pharmaceutical litigation attorneys. The Onder Law Firm, which handles cases on a national basis, is quickly becoming a leader in large and complex litigation. A partner in the firm was recently appointed as co-lead counsel in the Yaz lawsuit filed in U.S. District Court for the Southern District of Illinois (MDL No. 2100).

The FDA is currently evaluating interim safety findings in an ongoing study of XOLAIR problems. XOLAIR (omalizumab) is an injected drug for asthma related allergies. The interim results of this study, which is being conducted by the drug’s manufacturer, Genentech, Inc., suggests an increased number of cardiovascular (heart attack) and cerebrovascular (stroke) adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group). The possible association has been identified based on interim results from an ongoing study of Xolair known as Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS). The results this study are not expected until 2012. Although the FDA and the drug manufacturer have not recalled XOLAIR, the FDA wants consumers to be aware of increased risks from taking XOLAIR, specifically heart attack/heart disease and stroke.

The Onder Law Firm, attorneys for XOLAIR cases, have launched a site that contains information regarding XOLAIR side effects and the rights those suffering from them may have. The attorneys of The Onder Law Firm will review will provide free XOLAIR case review to persons having experienced side effects or medical problems after taking the drug. The Onder Law Firm provides experienced legal representation without fee unless it collects for its clients.

About The Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States in pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.

# # #

Read the full story at http://www.prweb.com/releases/xolair/lawyers/prweb3244494.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Verdict One Releases Directory of Board Certified Attorneys for Consumers
2. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
3. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
4. Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney
5. Social Security Attorneys Prepare for Increased Baby Boomer SSI Claims
6. Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
7. Social Security Attorneys Focus on Localized SEO Friendly Content
8. SumoBrain Adds Bulk PDF Downloading : Free Service Saves Money and Time for Attorneys, Inventors and Corporate IP Professionals
9. Cleveland Injury Attorneys Among 'The Best Lawyers in America'
10. Five Lubin & Meyer Lawyers Named Top Medical Malpractice Attorneys: Selected as Super Lawyers 2008
11. Jones Walker Attorneys Named to Positions in Order of British Crown
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... planning services from offices headquartered in Jefferson County, is announcing the launch of ... in Birmingham. , The number of homeless women and children in Birmingham has ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Markets has announced the addition of the "Endodontic Supplies - Global Strategic ... , ... for Endodontic Supplies in US$ Thousand. The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year historic analysis is ...
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: